On 6 Nov 2026, Star Imaging and Path Lab was priced at ₹74.00, or 6.7× trailing earnings, against an industry P/E of 52.8×, and the shares are 51% below their 52-week high. Sales grew 15% a year over 3 years, with ROCE of 23% and ROE of 24%. Debt is 0.18× equity. It is listed on an SME platform with a market cap of ₹129 Cr, ranked 14th of 18 Diagnostics & Research companies by market cap; the shares fell 48% over the past year.
- ₹74.00
- ₹74.00
- ₹73.99
- ₹74.00
- 4K
Health check
- ReturnsBehind
−48.2% over a year, better than 0 of 7 peers.
- Price tagCheaper
P/E 6.7 vs industry 52.8.
- GrowthStrong
Sales +14.7%, profit +221.7% a year over 3 years.
- ProfitabilityStrong
ROCE 22.6% vs peer median 19.1%.
- Balance sheetSolid
Debt 0.18× equity, interest covered 14.2×, Piotroski 7 of 9.
- Red flags1 to check
51% below its 52-week high.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹129 Cr
- Small cap
- P/E
- 6.7
- Industry 52.8
- Price to book
- 1.11
- Peers 11.99
- Dividend yield
- 0.00%
- ROE
- 23.5%
- Peers 17.7%
- ROCE
- 22.6%
- Peers 19.1%
- Debt to equity
- 0.18
- Debt ₹21 Cr
- EPS (TTM)
- ₹11.05
- OPM (TTM)
- 29.6%
- Net margin 21.8%
- Sales growth
- +5.9%
- Latest quarter vs a year ago
- Profit growth
- +82.5%
- Latest quarter vs a year ago
- Price to sales
- 1.46
- EV/EBITDA 3.0
Strengths and risks
Strengths
- Return on equity of 23.5%.
- Return on capital employed of 22.6%.
- Quarterly profit up 82.5% on a year ago.
- Net margin of 21.8%.
- P/E of 6.7 against an industry P/E of 52.8.
Risks to check
- 51% below its 52-week high.
About Star Imaging and Path Lab
Star Imaging and Path Lab Limited operate as a diagnostic testing network and provides diagnostic imaging services and clinical laboratory tests in India. It offers diagnostic and radiology services, which includes X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, 4D and 5D ultrasounds, bone mineral densitometry, mammography, and orthopantomogram, surgical/anatomic pathology; pathology services, includes hematology,…
- Headquarters
- New Delhi
- Employees
- 236
- Sector
- Healthcare
- ISIN
- INE0YG001013
- Website
- starimaging.in
Price range
- Avg volume (3M)
- 16.8K
- 1-year return
- minus 48.2%
- From 52-week high
- minus 51.3%
Peers · Diagnostics & Research
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SAILIFESai Life Sciences | 1,785.10 | plus 11.95% | 37,929 | 101.5 | 15.22 | 18.1% | 15.1% | 28.7% | 21.3% | 226.8% | 0.00% | plus 72.7% |
| LALPATHLABDr. Lal Path Labs | 1,970.00 | plus 0.16% | 32,941 | 56.5 | 11.99 | 25.7% | 22.6% | 30.2% | 11.1% | 28.3% | 1.02% | plus 24.7% |
| SYNGENESyngene International | 417.30 | plus 0.77% | 16,772 | 90.3 | 3.46 | 8.3% | 3.9% | 25.7% | 5.4% | −12.0% | 0.30% | minus 36.0% |
| VIJAYAVijaya Diagnostic Centre | 1,468.60 | plus 2.15% | 15,126 | 74.4 | 14.29 | 19.1% | 21.2% | 43.1% | 21.0% | 26.9% | 0.14% | plus 40.2% |
| METROPOLISMetropolis Healthcare | 568.75 | minus 0.39% | 11,803 | 52.8 | 7.17 | 15.7% | 14.6% | 21.7% | 12.7% | 10.0% | 0.35% | plus 12.5% |
| THYROCAREThyrocare Technologies | 493.10 | plus 0.68% | 7,848 | 55.0 | 14.75 | 33.8% | 26.4% | 32.2% | 16.7% | 36.2% | 1.89% | plus 8.3% |
| VIMTALABSVimta Labs | 496.45 | minus 2.14% | 2,219 | 27.9 | 4.52 | 21.0% | 17.7% | 34.7% | 8.9% | 17.2% | 0.40% | minus 23.3% |
| STARIMAGINStar Imaging and Path Lab | 74.00 | 0.00% | 129 | 6.7 | 1.11 | 22.6% | 23.5% | 29.6% | 14.7% | 221.7% | 0.00% | minus 48.2% |
| Median of 7 peers | – | 0.68% | 15,126 | 56.5 | 11.99 | 19.1% | 17.7% | 30.2% | 12.7% | 26.9% | 0.35% | 12.5% |
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
- Sales CAGR 3Y
- +14.7%
- Profit CAGR 3Y
- +221.7%
- ROE
- 23.5%
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| – | 58.7 | 80 | 83.5 | 88.5 | |
| – | – | +36.3% | +4.4% | +6.0% | |
| – | 53.2 | 56.6 | 54.9 | 55.6 | |
| – | 5.5 | 23.4 | 28.6 | 33 | |
| – | 9.4% | 29.2% | 34.3% | 37.2% | |
| – | 0.5 | −0.8 | 0.3 | 1.2 | |
| – | 1.7 | 2.2 | 2.5 | 2 | |
| – | 3.3 | 5.2 | 5 | 5.9 | |
| 0 | – | 1 | – | – | |
| – | 0.9 | 16.1 | 21.4 | 26.3 | |
| – | 34.4% | 22.7% | 25.2% | 25.0% | |
| – | 0.6 | 12.4 | 15.9 | 19.3 | |
| – | – | +2045.0% | +28.3% | +21.1% | |
| 3.61 | 0.33 | 7.13 | 9.14 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 1.5 | 1.5 | 13.5 | 17.4 | |
| 17.4 | 29.9 | 33.7 | 98.7 | |
| 26.6 | 30.6 | 32.7 | 20.7 | |
| 15.7 | 19.6 | 18.3 | 16.8 | |
| 61.2 | 81.6 | 98.2 | 154 | |
| 25.9 | 23.4 | 26 | 33.7 | |
| 6.9 | 1.7 | 5.1 | 8.5 | |
| 0.2 | 0.3 | 0.4 | 0.4 | |
| 2.4 | 15.7 | 5.3 | 51.6 | |
| 25.8 | 40.5 | 61.3 | 59.4 | |
| 61.2 | 81.6 | 98.2 | 154 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 5.3 | 18.3 | −2.6 | 23.3 | |
| −7.2 | −6.9 | −7.4 | −12.8 | |
| −4.7 | 1.9 | −0.4 | 35.7 | |
| −6.7 | 13.4 | −10.4 | 46.3 | |
| −7.3 | −8.4 | −4.2 | −10.2 | |
| −2 | 9.9 | −6.9 | 13.1 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders. Institutions hold about 3.8% (Yahoo estimate).
Major shareholders
Filings & events
News
No recent news coverage found.